| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 35 |
| 1 | LATANOPROST | 21 |
| 2 | PANITUMUMAB | 19 |
| 3 | PREDNISONE | 19 |
| 4 | CIPROFLOXACIN HYDROCHLORIDE | 18 |
| 5 | FLUTICASONE PROPIONATE | 18 |
| 6 | CAPECITABINE | 17 |
| 7 | FLUOROURACIL | 16 |
| 8 | CIPROFLOXACIN | 15 |
| 9 | CIPROFLOXACIN TABLETS | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRACAINE HYDROCHLORIDE | 1 | 0.0075 |
| 1 | CASTOR OIL | 1 | 0.0052 |
| 2 | DEXTRAN, HYPROMELLOSE | 1 | 0.0043 |
| 3 | TETRAHYDROZOLINE HYDROCHLORIDE | 1 | 0.0034 |
| 4 | CLARIFYING DETOX (ACNE TREATMENT) MASK | 1 | 0.0029 |
| 5 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | 1 | 0.0018 |
| 7 | SORBITOL | 1 | 0.0017 |
| 8 | PYRITHIONE ZINC | 1 | 0.0016 |
| 9 | VINORELBINE | 10 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 35 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 35 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 28 |
| 3 | Prostaglandin Analog [EPC] | 24 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 22 |
| 6 | Vitamin D [EPC] | 19 |
| 7 | Vitamin C [EPC] | 18 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 17 |
| 9 | Vitamin B12 [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 10 | 0.0010 |
| 1 | Nitrogen Binding Agent [EPC] | 2 | 0.0008 |
| 2 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Ectoparasiticide [EPC] | 2 | 0.0005 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 22 | 0.0005 |
| 6 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 7 | Calcitonin [EPC] | 1 | 0.0003 |
| 8 | Hedgehog Pathway Inhibitor [EPC] | 3 | 0.0003 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |